Brighton, MA, United States of America

Stephen C Harrison

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Cambridge, MA (US) (2003 - 2014)
  • Boston, MA (US) (2018 - 2021)
  • Brighton, MA (US) (2014 - 2022)

Company Filing History:


Years Active: 2003-2022

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):

Title: The Innovative Journey of Stephen C. Harrison

Introduction

Stephen C. Harrison, a prominent inventor based in Brighton, MA, has made significant contributions to the field of biomedical research. With a remarkable portfolio of 18 patents, Harrison has dedicated his career to finding solutions to some of the most pressing health challenges, particularly in the realm of viral infections.

Latest Patents

Among his latest inventions is a biochemically stabilized HIV-1 Env trimer vaccine, which focuses on offering protection against HIV-1 by stabilizing trimers of clade A and clade C strains. This pioneering work also embraces the development of broadly neutralizing antisera against HIV-1, providing methods of production, as well as innovative strategies for treating and preventing HIV infections. Additionally, Harrison has created compositions and methods targeted at treating arenavirus infections. This invention emphasizes the importance of using agents that inhibit the binding of arenavirus glycoprotein 1 (GP1) polypeptide to transferrin receptor 1 (TfR1), alongside methods for identifying therapeutic agents that target this crucial receptor-binding site.

Career Highlights

Stephen C. Harrison's career is marked by significant milestones, having worked with esteemed institutions such as Children's Medical Center Corporation and Duke University. His experience in these organizations has enriched his insights into medical research and innovation, fostering an environment conducive to groundbreaking discoveries.

Collaborations

Throughout his career, Harrison has collaborated with notable individuals in the field, including Bing Chen and Michael Scott Seaman. These partnerships have been instrumental in advancing his research and contributing to his impressive array of patents.

Conclusion

In conclusion, Stephen C. Harrison stands as a vital figure in the landscape of biomedical innovation. His dedication to developing vaccines and treatment methods for viral infections not only showcases his ingenuity but also his commitment to improving public health outcomes. With a continued focus on research and collaboration, Harrison’s contributions are likely to resonate in the medical community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…